Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Efficacy of the GABA-B receptor agonist CGP-44532 in response to nicotine

Feb. 16, 2005

Subutex approved in Canada for opiate addiction treatment

Feb. 15, 2005

Neuropeptide Y Y2 antagonist effective in rats with ethanol dependence

Feb. 14, 2005

RiVax ricin vaccine enters clinical testing

Feb. 9, 2005

SR-147778: further evidence that CB1 antagonism may be effective for the treatment of alcoholism

Feb. 8, 2005

New varenicline formulations for smoking cessation reported by Pfizer

Feb. 4, 2005

GDNF shows promise as a novel target for treating alcohol abuse

Feb. 3, 2005

NIDA grant supports drug addiction therapy development at InfleXion

Feb. 1, 2005

Phase IIa Tetrodin study completes enrollment

Jan. 20, 2005

Campral available in U.S.

Jan. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...